Winmill & Co’s Amgen AMGN Stock Holding History

Winmill & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,050	Closed	-$3.84M	–	79
2021 Q3	$3.84M	Hold	18,050	–	–	1.23%	37
2021 Q2	$4.4M	Hold	18,050	–	–	1.58%	27
2021 Q1	$4.49M	Hold	18,050	–	–	1.66%	25
2020 Q4	$4.15M	Hold	18,050	–	–	1.63%	24
2020 Q3	$4.59M	Hold	18,050	–	–	1.88%	15
2020 Q2	$4.26M	Buy	18,050 +1,050	+6%	+$240K	1.71%	14
2020 Q1	$3.45M	Hold	17,000	–	–	1.87%	10
2019 Q4	$4.1M	Hold	17,000	–	–	1.4%	18
2019 Q3	$3.29M	Buy	+17,000	New	+$3.26M	1.4%	17

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winmill & Co's AMGN Position: Q4 2021 in Review

Winmill & Co sold out of Amgen (AMGN) in Q4 2021, closing a stake of 18,050 shares — an estimated $3.84M sold.

Winmill & Co first reported a position in AMGN in Q3 2019 and held it in 9 quarters. The position peaked at $4.59M in Q3 2020. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

Winmill & Co reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
Winmill & Co sold 18,050 Amgen shares in Q4 2021, an estimated $3.84M.
Winmill & Co first reported a position in Amgen in Q3 2019 and held it in 9 quarters.
Winmill & Co's Amgen position peaked at $4.59M in Q3 2020.
2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Winmill & Co's 13F filing for Q4 2021, filed 11 Feb 2022.